1. LBA23FOLFOX4/XELOX in stage II–III colon cancer: Efficacy and safety results of the Italian Three Or Six Colon Adjuvant (TOSCA) trial. (18th September 2017) Authors: Labianca, R.; Lonardi, S.; Rosati, G.; Di Bartolomeo, M.; Ronzoni, M.; Pella, N.; Scartozzi, M.; Banzi, M.; Zampino, M.G.; Pasini, F.; Marchetti, P.; Cantore, M.; Zaniboni, A.; Rimassa, L.; Ciuffreda, L.; Barni, S.; Zagonel, V.; Maiello, E.; Rulli, E.; Sobrero, A. Journal: Annals of oncology Issue: Volume 28(2017)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OC-1a: A prospective study of hemostatic biomarkers to predict early recurrence in high-risk breast cancer women undergoing post-surgical adjuvant systemic therapy. Issue 151 (March 2017) Authors: Marchetti, M.; Masci, G.; Verzeroli, C.; Giaccherini, C.; Celio, L.; Merelli, B.; Sarmiento, R.; Brevi, S.; Gamba, S.; Milesi, V.; Russo, L.; Tartari, C.J.; Malighetti, P.; Spinelli, D.; De Braud, F.; Labianca, R.; Gasparini, G.; Santoro, A.; Falanga, A. Journal: Thrombosis research Issue: Issue 151(2017)Supplement 1 Page Start: S103 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗